Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • BW TV
  • Subscribe to Print

Latest Articles in BioNTech Pfizer

Dermapharm Aims To Start Making Pfizer Shot At Second Site By May

Dermapharm made a "significant share" of the 50 million doses produced in 2020 and is doubling its production capacity to help deliver 75 million extra doses to the European Union in the second quarter

Read More

Experts, politicians slam Germany for not buying adequate coronavirus vaccine doses

Experts, politicians slam Germany for not buying adequate coronavirus vaccine doses

Read More

COVID-19 Vaccine Sprint As Pfizer-Biontech, Moderna Seek Emergency EU Approval

Pfizer and BioNTech reported final trial results on Nov. 18 that showed their vaccine candidate, known as BNT162b2, was 95% effective in preventing COVID-19, with no major safety concerns.

Read More

Pfizer Files COVID-19 Vaccine Application To US FDA

Pfizer's shares closed up 1.4% and BioNTech shares ended 9.6% higher in New York, as the possibility of a vaccine soon raised hopes for the end of a pandemic that has claimed more than a quarter of a million lives in the United States and over 1.3 million worldwide.

Read More

Pfizer, BioNTech Conclude Phase 3 Study Of COVID-19 Vaccine Candidate, Say It's 95% Effective

The major announcement comes just two days after leading biotechnology company Moderna said on Monday its virus vaccine had an efficacy rate of 94.5 per cent

Read More

Wall Street Dives As Shutdown Worries Overshadow Vaccine Hopes

The Dow Jones Industrial Average fell 344.93 points, or 1.16%, to 29,438.42, the S&P 500 lost 41.74 points, or 1.16%, to 3,567.79 and the Nasdaq Composite dropped 97.74 points, or 0.82%, to 11,801.60.

Read More

Pfizer-BioNTech Vaccine Deliveries Could Start 'Before Christmas'

Global shares rose as the trial results countered concerns around the soaring infection rate. Pfizer shares were up 1.6% while BioNTech jumped 3.8% in the United States. Moderna shares fell 3.6%.

Read More

BioNTech CEO Expects Vaccine Can Be Fridge-Stored For Two Weeks

A good vaccine should have an efficacy of at least 70% to 75% for it to quell the pandemic and that was also the yardstick that BioNTech had set itself.

Read More

Covid-19 Vaccine Status: Here's All You Need To Know

Here is the latest update on COVID-19 vaccines from different pharmaceutical companies

Read More